$134.00
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. The company is headquartered in Santa Clara, California and currently employs 18,000 full-time employees. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. The Life Sciences and Diagnostics Markets segment provides contract development and manufacturing services for pharmaceutical customers as well as solutions that include reagents, instruments, software and consumables which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. The Agilent CrossLab segment spans the entire lab with its services and consumables portfolio in addition to software and laboratory automation solutions, which are designed to improve customer outcomes and represent a range of offerings designed to serve customer needs across end-markets and applications.
Country

US

CEO

Mr. Padraig McDonnell

IPO date

1999

Employees

18,000

ISIN

US00846U1016

Key stats

Open

$129.07

Volume

2.37M

Market cap

$36.45B

Prev. close

$133.59

Impl / hst vl

-

Open interest

$0.00

$127.87

Day’s Range

$134.00

$108.35

52W Range

$150.10

Valuation

66
Valuation score
Undervalued
P/E
25.71
P/S
5.03
P/B
5.10
Current ratio
2.10
Debt / Equity
0.22
ROE
20.84%
Gross margin
54.11%
Income growth
11.15%
FCF growth
14.86

Jul

22

Dividends

The last payment date was Jul 22, 2026

Div. per Share

$0.26

Div. Yield

0.20%

Payout Ratio

20.16%

Div. Growth YoY

-50.00%

Analysts estimates

Consensus rating
Buy

The average rating from top 15 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$163.70
The top 23 analysts forecasts that 12-month price may increase by 22.16%, with a low of $145.44 and a high of $194.25
$145.44
Low
$163.70
Avg
$194.25
High
Current price

Earnings

Q2 ‘26 revenue
$1.84B
Q2 ‘26 net income
$339.00M
Revenue
Net income
Previous EPS
$1.49
Estimate EPS
$1.52
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply